Invirase

Invirase is a brand name of saquinavir, approved by the FDA in the following formulation(s):

INVIRASE (saquinavir mesylate - capsule; oral)

• 
  Manufacturer: HOFFMANN LA ROCHE
  
  Approval date: December 6, 1995
  
  Strength(s): EQ 200MG BASE ^[RLD]

INVIRASE (saquinavir mesylate - tablet; oral)

• 
  Manufacturer: ROCHE
  
  Approval date: December 17, 2004
  
  Strength(s): EQ 500MG BASE ^[RLD]

Has a generic version of Invirase been approved?

No. There is currently no therapeutically equivalent version of Invirase available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Invirase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Invirase.

See also...

• Invirase Consumer Information (Drugs.com)
• Invirase Consumer Information (Wolters Kluwer)
• Invirase Consumer Information (Cerner Multum)
• Invirase Advanced Consumer Information (Micromedex)
• Invirase AHFS DI Monographs (ASHP)
• Saquinavir Consumer Information (Wolters Kluwer)
• Saquinavir Mesylate Consumer Information (Wolters Kluwer)
• Saquinavir Consumer Information (Cerner Multum)
• Saquinavir Advanced Consumer Information (Micromedex)
• Saquinavir AHFS DI Monographs (ASHP)